lactoferrinFinding
Lactoferrin decreases late-onset sepsis incidence (neonatal)
lowersVery limited evidenceFindingreplicated ×2
01 · The sentence it was drawn from
“Meta-analysis of data from twelve randomized controlled trials showed that lactoferrin supplementation to enteral feeds decreased late-onset sepsis (typical RR 0.82, 95% CI 0.74 to 0.91; typical RD -0.04, 95% CI, -0.06, -0.02; NNTB 25, 95% CI 17 to 50; 12 studies, 5425 participants, low-certainty evidence) and decreased length of hospital stay (MD -2.38, 95% CI, -4.67, -0.09; 3 studies, 1079 participants, low-certainty evidence).”
lactoferrin
Late- onset sepsis incidence (neonatal)
lowers
Effect as reported
0.82risk ratio
CI 0.74 to 0.91
- Who
- n = 5,425 · preterm neonates in randomised and quasi-randomised trials of lactoferrin added to enteral feeds (12 trials pooled)
- Dose studied
- not reported
Very limited evidencePMID 32232984 · 2020
02 · The study
- Study
- meta-analysis
- Participants
- 5,425
- Duration
- not reported
Evidence, by strength
- strong
- moderate
- limited
- very limitedthis finding
- insufficient
03 · The paper
The Cochrane database of systematic reviews04 · To cite this finding
This address does not changehttps://catalystproject.ai/e/01M7PF1ZSB2KHCP8WK947WCHVV